X

Trial Profile

A Pharmacokinetic Study for Systemic Exposure of Twice Daily Topically Applied GSK2894512 Cream in Subjects With Atopic Dermatitis

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 26 Jun 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tapinarof (Primary)
Indications Atopic dermatitis
Focus Adverse reactions; Pharmacokinetics
Sponsors GlaxoSmithKline; GSK

Most Recent Events

01 Jul 2018 Results published in the Clinical Pharmacology in Drug Development
10 Nov 2015 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
23 Oct 2015 Planned end date changed from 1 Aug 2015 to 1 Oct 2015, as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com